257 related articles for article (PubMed ID: 28654775)
1. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P
J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis.
Jiang XW; Ye JZ; Li YT; Li LJ
World J Gastroenterol; 2018 Jul; 24(28):3181-3191. PubMed ID: 30065564
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapy.
Zarębska-Michaluk D; Brzdęk M; Rzymski P; Dobrowolska K; Flisiak R
Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38164525
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).
Blackard JT; Sherman KE
Rev Med Virol; 2018 Jul; 28(4):e1984. PubMed ID: 29761585
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.
Patel NH; Meier-Stephenson V; Genetu M; Damtie D; Abate E; Alemu S; Aleka Y; Van Marle G; Fonseca K; Coffin CS; Deressa T
PLoS One; 2020; 15(11):e0242577. PubMed ID: 33211768
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.
Aggeletopoulou I; Konstantakis C; Manolakopoulos S; Triantos C
World J Gastroenterol; 2017 Jun; 23(24):4317-4323. PubMed ID: 28706414
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
Aurpibul L; Kariminia A; Vibol U; Fong MS; Le ON; Hansudewechakul R; Bunupuradah T; Kurniati N; Chokephaibulkit K; Kumarasamy N; Wati DK; Yusoff NKN; Razali KAM; Nallusamy RA; Sohn AH; Lumbiganon P;
Pediatr Infect Dis J; 2018 Aug; 37(8):788-793. PubMed ID: 29846357
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Reactivation Following Eradication of HCV with Direct-Acting Antiviral Drugs (DAAs) in a Cohort of Patients from Different Institutions in Egypt.
Abdelbary MS; Samir R; El-Nahaas SM; Shahin RMH; El-Sayed M; Gaber Y; Tantawi O; Zayed NA; Yosry A
J Clin Exp Hepatol; 2022; 12(5):1276-1284. PubMed ID: 36157140
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus and Hepatitis B Virus Co-Infection.
Shih YF; Liu CJ
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study.
Onozawa M; Kusumoto S; Najima Y; Hashimoto H; Okada K; Tamaki M; Tanaka M; Sato T; Takahashi T; Hatano K; Onodera K; Moriuchi Y; Yakushijin K; Kanda J; Nagafuji K; Ogata M; Nakano N; Tamori A; Mizokami M
Transplant Cell Ther; 2024 Mar; 30(3):330.e1-330.e8. PubMed ID: 38242442
[TBL] [Abstract][Full Text] [Related]
11. Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation.
Tamori A; Kimura K; Kioka K; Enomoto H; Odagiri N; Kozuka R; Uchida-Kobayashi S; Enomoto M; Kawada N; Mizokami M
J Med Virol; 2021 Jun; 93(6):3679-3687. PubMed ID: 32940921
[TBL] [Abstract][Full Text] [Related]
12. Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection.
Liu S; He Z; Wu W; Jin H; Cui Y
Clin Rheumatol; 2023 Sep; 42(9):2369-2376. PubMed ID: 37219751
[TBL] [Abstract][Full Text] [Related]
13. Moderate Risk of Hepatitis B Virus Reactivation in HBsAg
Kuo MH; Tseng CW; Lee CH; Tung CH; Tseng KC; Lai NS
Sci Rep; 2020 Feb; 10(1):2456. PubMed ID: 32051458
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation.
Ohkubo M; Seo E; Doki K; Suzuki Y; Sekine I; Homma M
Biol Pharm Bull; 2024; 47(5):941-945. PubMed ID: 38735754
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study.
Marzo B; Vidal-Jordana A; Castilló J; Robles-Sanchez MA; Otero-Romero S; Tintore M; Montalban X; Buti M; Riveiro-Barciela M
J Neurol; 2024 Jan; 271(1):134-140. PubMed ID: 37695530
[TBL] [Abstract][Full Text] [Related]
16. Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients.
Brost S; Schnitzler P; Stremmel W; Eisenbach C
World J Gastroenterol; 2010 Nov; 16(43):5447-51. PubMed ID: 21086562
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment.
Axiaris G; Zampeli E; Michopoulos S; Bamias G
World J Gastroenterol; 2021 Jul; 27(25):3762-3779. PubMed ID: 34321842
[TBL] [Abstract][Full Text] [Related]
18. Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.
Poola S; Kratzer M; Sewell K; Tillmann HL
Dig Dis Sci; 2023 Dec; 68(12):4511-4520. PubMed ID: 37891440
[TBL] [Abstract][Full Text] [Related]
19. Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors.
Niizuma K; Ogawa Y; Kogure T; Tominaga T
BMC Infect Dis; 2020 Mar; 20(1):230. PubMed ID: 32188424
[TBL] [Abstract][Full Text] [Related]
20. Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
He MK; Peng C; Zhao Y; Liang RB; Lai ZC; Kan A; Li QJ; Wei W; Zhang YJ; Chen MS; Guo RP; Shi M
Cancer Immunol Immunother; 2021 Nov; 70(11):3207-3216. PubMed ID: 33813646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
